Literature DB >> 31553303

Genomic and phenotypic comparison of environmental and patient-derived isolates of Pseudomonas aeruginosa suggest that antimicrobial resistance is rare within the environment.

Kay A Ramsay1, Samuel J T Wardell1, Wayne M Patrick2, Ben Brockway3, David W Reid4,5, Craig Winstanley6, Scott C Bell7,4,5, Iain L Lamont1.   

Abstract

Patient-derived isolates of the opportunistic pathogen Pseudomonas aeruginosa are frequently resistant to antibiotics due to the presence of sequence variants in resistance-associated genes. However, the frequency of antibiotic resistance and of resistance-associated sequence variants in environmental isolates of P. aeruginosa has not been well studied. Antimicrobial susceptibility testing (ciprofloxacin, ceftazidime, meropenem, tobramycin) of environmental (n=50) and cystic fibrosis (n=42) P. aeruginosa isolates was carried out. Following whole genome sequencing of all isolates, 25 resistance-associated genes were analysed for the presence of likely function-altering sequence variants. Environmental isolates were susceptible to all antibiotics with one exception, whereas patient-derived isolates had significant frequencies of resistance to each antibiotic and a greater number of likely resistance-associated genetic variants. These findings indicate that the natural environment does not act as a reservoir of antibiotic-resistant P. aeruginosa, supporting a model in which antibiotic susceptible environmental bacteria infect patients and develop resistance during infection.

Entities:  

Keywords:  Pseudomonas aeruginosa environmental antibiotic resistance genetic variant cystic fibrosis

Mesh:

Substances:

Year:  2019        PMID: 31553303     DOI: 10.1099/jmm.0.001085

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa.

Authors:  Samuel J T Wardell; Attika Rehman; Lois W Martin; Craig Winstanley; Wayne M Patrick; Iain L Lamont
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

2.  Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the Pseudomonas aeruginosa Clinical Strains.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Joanna Kwiecińska-Piróg; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2021-02-28

3.  Carbapenem-Resistant Pseudomonas aeruginosa Strains-Distribution of the Essential Enzymatic Virulence Factors Genes.

Authors:  Tomasz Bogiel; Małgorzata Prażyńska; Joanna Kwiecińska-Piróg; Agnieszka Mikucka; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2020-12-24

4.  Genome evolution drives transcriptomic and phenotypic adaptation in Pseudomonas aeruginosa during 20 years of infection.

Authors:  Samuel J T Wardell; Jeff Gauthier; Lois W Martin; Marianne Potvin; Ben Brockway; Roger C Levesque; Iain L Lamont
Journal:  Microb Genom       Date:  2021-11

Review 5.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18

6.  Evaluation of Multidrug-Resistant P. aeruginosa in Healthcare Facility Water Systems.

Authors:  Maria Luisa Cristina; Marina Sartini; Elisa Schinca; Gianluca Ottria; Beatrice Casini; Anna Maria Spagnolo
Journal:  Antibiotics (Basel)       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.